Concerta ER 18 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FJVEP
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,114
Award facts
- Contract value 100% obligated
- $16,114.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16.1K delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Concerta ER 18 mg tablets (100-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 9, 2025. This award carries no set-aside designation and represents a continuation of Dakota Drug's ongoing supply relationship with DLA, leveraging the company's established capability as a critical pharmaceutical vendor to the U.S. military healthcare system.
This delivery order falls under Dakota Drug's larger Indefinite Delivery Contract with DLA Troop Support Medical's ECAT Generation V Program (Contract SPE2DB24D8001), valued at $999.9M and extending through December 31, 2025. The parent IDC, originating from solicitation SPE2DH-21-R-0002, authorizes the company to provide a comprehensive range of pharmaceutical products and medical supplies to support U.S. Armed Forces medical operations. Dakota Drug's demonstrated track record supplying critical medications including pain management drugs, neurological prescriptions, and other pharmaceuticals positions it as a strategic supplier within the military medical supply chain, with this specific delivery fulfilling an immediate requirement for attention-deficit medication needed by defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FJVEP?
SPE2DB25FJVEP was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FJVEP worth?
The government has obligated $16,114 on SPE2DB25FJVEP.
Is contract SPE2DB25FJVEP an order under another contract?
Yes. SPE2DB25FJVEP is a delivery order under SPE2DB24D8003, an indefinite delivery contract.
Was contract SPE2DB25FJVEP competed?
The extent of competition for SPE2DB25FJVEP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award